Will Amgen say “GLP-1 / GLP”?
Amgen said “GLP-1 / GLP” 4 times on its Nov 3, 2026 call (FY26 Q3), and on 6 of its last 8 calls: 0, 3, 0, 1, 1, 7, 6, 4 times. As of Nov 11, 2026, Amgen said “GLP-1 / GLP” on the only call with a settled Kalshi mention market so far, on Nov 3, 2026. Parrot’s p for the next listing is 85% (n=1, from settlement history blended with transcripts), not a forecast.
- Last 10
- 1/1Last 10 settled, oldest to newest: yes
- Streak
- said last time
- Counts
- company speakers + operator
- Market
- 78¢ Kalshi (may be delayed)
Where it was said
quotes of at most 25 words; select an appearanceAmgen
GLP-1 / GLP
- Probability
- 85% · n=1
- Settled
- 1/1 (100%)
- Last calls
- said in 6 of 8
Next listing counts: company speakers + operator
Counts: company speakers + operator
4 counted (1 in prepared remarks, 3 in Q&A); 1 by speakers the rule does not count.
…start and stay on MariTide, and how others can switch from other GLP-1-based medicines and stay on MariTide. Our goal is to make long-term treatment…
…medicine that has a very long half-life, designed for tonic activation of GLP-1 receptors as well as inhibition of GIP receptors, that has conferred activity…
Counts: company speakers + operator (not listed here; the usual rule)
6 counted (4 in prepared remarks, 2 in Q&A); 1 by speakers the rule does not count.
…course, obesity. Our lead obesity asset, MariTide, is fundamentally different from other GLP-1 therapies, as MariTide is uniquely designed for monthly therapy with the potential…
…to start and stay on MariTide, and how to switch from other GLP-1 based therapies and stay on MariTide. One, start and stay on MariTide.…
Counts: company speakers + operator (not listed here; the usual rule)
7 counted (1 in prepared remarks, 6 in Q&A); 1 by speakers the rule does not count.
…another new Phase III study that will evaluate switching from weekly injectable GLP-1 therapies to MariTide following dose escalation to a convenient every 8-week or…
Every settled listing
newest first · 1 shown| Date | Listed as | Venue | Result | Our count |
|---|---|---|---|---|
| Nov 3, 2026 | GLP-1 / GLP |  Kalshi | Yes | 4 |
Questions
- How many times did Amgen say “GLP-1 / GLP” on its last earnings call?
- Amgen said “GLP-1 / GLP” 4 times on its Nov 3, 2026 call (FY26 Q3), and on 6 of its last 8 calls: 0, 3, 0, 1, 1, 7, 6, 4 times.
- How often does Amgen say “GLP-1 / GLP”?
- As of Nov 11, 2026, Amgen said “GLP-1 / GLP” on the only call with a settled Kalshi mention market so far, on Nov 3, 2026.
- What is the probability Amgen says “GLP-1 / GLP” next time?
- 85%, from settlement history blended with transcripts (n=1). It is a base rate from history, not a forecast and not advice.
- Who has to say it for the market to count?
- Under the next market's rule: company speakers + operator.
Cite parrot.markets, “Amgen: ‘GLP-1 / GLP’ mention history”, as of Nov 11, 2026, https://parrot.markets/earnings/AMGN/words/glp-or-glp-1 (CC BY 4.0)
Agents: this page as TSV at /api/v1/word?entity=amgen&word=glp%20%2F%20glp%201 · quotes: /api/v1/quotes?entity=amgen&word=… · columnar JSON in #parrot-data · llms.txt · MCP